| Literature DB >> 36078236 |
Avi Magid1, Eliezer Robinson2,3, Lital Keinan-Boker4,5.
Abstract
Background: The cancer burden in Israel is substantial. Recently calculated population attributable fractions (PAFs) for modifiable cancer risk factors in the US and the UK have indicated much room for prevention. Our aim was to estimate PAFs for selected modifiable cancer risk factors in Israel.Entities:
Keywords: Israel; cancer; modifiable risk factors; population-attributable-fraction; prevention
Mesh:
Year: 2022 PMID: 36078236 PMCID: PMC9518384 DOI: 10.3390/ijerph191710521
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Factors associated with increased cancer risk (by cancer type, ICD-10) used in this study.
| Risk Factor | Cancer Type (ICD-10) |
|---|---|
| Smoking | Stomach (C16); colorectum (C18-C20, C26.0); pancreas (C25); lung (C33-C34); kidney (C64-C66); urinary bladder (C67) |
| Excess body weight | Stomach (C16); colorectum (C18-C20, C26.0); pancreas (C25); female breast (C50); corpus uteri (C54-C55); ovary (C56); kidney (C64-C66); thyroid (C73) |
| Alcohol intake | Colorectum (C18-C20, C26.0); female breast (C50) |
| Red meat consumption | Colorectum (C18-C20, C26.0) |
| Processed meat consumption | Colorectum (C18-C20, C26.0); stomach (C16) |
Estimates cancer cases in adults aged 30 years and older in Israel in 2015 attributable to potentially modifiable risk factors by sex, risk factor, and cancer type, compared to the US.
| MEN | WOMEN | BOTH | ||||
|---|---|---|---|---|---|---|
| Cancer | % PAF (95% CI) | Attributable Cases | % PAF (95% CI) | Attributable Cases | % PAF (95% CI) | Attributable Cases |
|
| ||||||
| Lung | 87 (83.5–90.5) | 1375 | 81 (76.8–85.2) | 738 | 85 (81.7–88.3) | 2104 |
| Pancreas | 16 (12.1–19.9) | 72 | 11 (8.2–13.8) | 46 | 13 (11.3–14.7) | 115 |
| Stomach | 22 (19.8–24.2) | 94 | 14 (10.3–17.7) | 40 | 18 (15.6–20.4) | 128 |
| Kidney | 20 (15.1–24.9) | 115 | 13 (10.9–15.1) | 35 | 16 (12.7–19.3) | 139 |
| Colorectum | 15 (13.9–16.1) | 233 | 9 (8.1–9.9) | 149 | 12 (11.1–12.9) | 378 |
| Bladder | 52 (45.9–58.1) | 652 | 40 (35.5–44.5) | 117 | 46 (42.2–49.8) | 714 |
|
| ||||||
| Corpus uteri | -- | -- | 30 (27.2–32.8) | 228 | 30 (27.2–32.8) | 228 |
| Kidney | 18 (16.4–19.6) | 109 | 24 (23.2–24.8) | 67 | 26 (25.5–26.5) | 219 |
| Stomach | 19 (17.7–20.3) | 80 | 16 (13.9–18.1) | 46 | 18 (16.3–19.7) | 124 |
| Pancreas | 10 (9.6–10.4) | 46 | 7 (6.3–7.7) | 27 | 9 (8.1–9.9) | 80 |
| Thyroid | 9 (7.6–10.4) | 23 | 8 (7.1–8.9) | 62 | 9 (7.7–10.3) | 87 |
| Breast | -- | -- | 8 (6.9–9.1) | 423 | 8 (6.9–9.1) | 423 |
| Colorectum | 14 (13.2–14.8) | 207 | 5 (4.9–5.1) | 83 | 13 (11.6–14.4) | 387 |
| Ovary | -- | -- | 5 (4.7–5.3) | 18 | 5 (4.7–5.3) | 18 |
|
| ||||||
| Breast | -- | -- | 4 (3.6–4.4) | 229 | 4 (3.6–4.4) | 229 |
| Colorectum | 1 (0.8–1.2) | 23 | 0.3 (0.1–0.5) | 5 | 1 (0.8–1.2) | 30 |
|
| ||||||
| Colorectum | 2 (1.5–2.5) | 34 | 1 (0.8–1.2) | 22 | 2 (1.7–2.3) | 54 |
|
| ||||||
| Colorectum | 0.6 (0.2–1.0) | 8 | 0.3 (0.1–0.5) | 4 | 0.4 (0.1–0.7) | 12 |
| Stomach | 0.7 (0.2–1.2) | 3 | 0.4 (0.1–0.7) | 1 | 0.5 (0.3–0.7) | 4 |
Estimates cancer cases in Jewish adults aged 30 years and older in Israel in 2015 attributable to potentially modifiable risk factors by sex, risk factor, and cancer type.
| MEN | WOMEN | BOTH | ||||
|---|---|---|---|---|---|---|
| Cancer | % PAF (95% CI) | Attributable Cases | % PAF (95% CI) | Attributable Cases | % PAF (95% CI) | Attributable Cases |
|
| ||||||
| Lung | 86 (82.3–89.7) | 1068 | 82 (78.5–85.5) | 680 | 85 (81.2–88.8) | 1747 |
| Pancreas | 14 (12.4–15.6) | 56 | 12 (10.8–13.2) | 43 | 13 (11.6–14.4) | 100 |
| Stomach | 20 (19.8–20.2) | 74 | 16 (14.3–17.7) | 36 | 18 (16.4–19.6) | 108 |
| Kidney | 19 (16.6–21.4) | 94 | 14 (11.9–16.1) | 31 | 17 (14.8–19.2) | 120 |
| Colorectum | 14 (13.2–14.8) | 182 | 11 (10.4–11.6) | 138 | 13 (12.3–13.7) | 323 |
| Bladder | 51 (46.6–55.4) | 540 | 42 (38.1–45.9) | 110 | 47 (43.0–51.0) | 621 |
|
| ||||||
| Corpus uteri | -- | -- | 28 (26.9–29.1) | 173 | 28 (26.9–29.1) | 173 |
| Kidney | 18 (17.1–18.9) | 90 | 23 (21.9–24.1) | 53 | 25 (23.7–26.3) | 181 |
| Stomach | 18 (15.6–20.4) | 66 | 15 (13.1–16.9) | 36 | 17 (15.0–19.0) | 102 |
| Pancreas | 10 (9.3–10.7) | 40 | 6 (5.7–6.3) | 23 | 7 (6.6–7.4) | 58 |
| Thyroid | 9 (7.6–10.4) | 20 | 8 (6.4–9.6) | 47 | 8 (6.4–9.6) | 71 |
| Breast | -- | -- | 7 (6.7–7.3) | 344 | 7 (6.7–7.3) | 344 |
| Colorectum | 13 (11.1–14.9) | 171 | 5 (4.6–5.5) | 67 | 12 (10.8–13.2) | 322 |
| Ovary | -- | -- | 4 (3.8–4.2) | 14 | 4 (3.8–4.2) | 14 |
|
| ||||||
| Breast | -- | -- | 4 (3.6–4.4) | 198 | 4 (3.6–4.4) | 198 |
| Colorectum | 1 (0.97–1.03) | 19 | 0.3 (0.28–0.32) | 4 | 0.1 (0.07–0.13) | 26 |
|
| ||||||
| Colorectum | 2 (1.95–2.05) | 26 | 1 (0.97–1.03) | 17 | 2 (1.95–2.05) | 43 |
|
| ||||||
| Colorectum | 0.7 (0.66–0.74) | 7 | 0.3 (0.27–0.33) | 3 | 0.4 (0.35–0.45) | 10 |
| Stomach | 0.7 (0.68–0.72) | 3 | 0.4 (0.35–0.45) | 1 | 0.5 (0.49–0.51) | 4 |
Estimates cancer cases in Arab adults aged 30 years and older in Israel in 2015 attributable to potentially modifiable risk factors by sex, risk factor, and cancer type.
| MEN | WOMEN | BOTH | ||||
|---|---|---|---|---|---|---|
| Cancer | % PAF (95% CI) | Attributable Cases | % PAF (95% CI) | Attributable Cases | % PAF (95% CI) | Attributable Cases |
|
| ||||||
| Lung | 91 (86.5–95.5) | 217 | 67 (63.5–70.5) | 32 | 86 (81.8–90.2) | 246 |
| Pancreas | 24 (21.1–26.9) | 7 | 6 (4.9–7.1) | 2 | 16 (14.7–17.3) | 9 |
| Stomach | 28 (25.5–30.6) | 10 | 7 (5.2–8.8) | 2 | 19 (15.6–22.4) | 11 |
| Kidney | 24 (21.2–26.8) | 13 | 6 (5.1–6.9) | 1 | 15 (11.9–18.1) | 12 |
| Colorectum | 20 (19.1–20.9) | 32 | 5 (4.8–5.2) | 7 | 13 (12.3–13.7) | 39 |
| Blader | 60 (56.7–63.3) | 71 | 22 (19.1–24.9 | 4 | 47 (44.0–50.0) | 64 |
|
| ||||||
| Corpus uteri | -- | -- | 38 (35.8–40.2) | 33 | 38 (35.8–40.2) | 33 |
| Kidney | 20 (18.1–21.9) | 11 | 31 (29.3–32.7) | 8 | 30 (28.8–31.2) | 23 |
| Stomach | 20 (17.2–22.8) | 7 | 22 (20.9–23.1) | 6 | 21 (19.5–22.5) | 13 |
| Pancreas | 11 (10.4–11.6) | 3 | 9 (8.1–9.9) | 2 | 11 (10.4–11.6) | 6 |
| Thyroid | 10 (9.3–10.7) | 2 | 11 (10.4–11.6) | 12 | 11 (10.4–11.6) | 13 |
| Breast | -- | -- | 10 (9.6–10.4) | 51 | 10 (9.6–10.4) | 51 |
| Colorectum | 15 (12.4–17.6) | 23 | 8 (6.3–9.7) | 11 | 15 (12.4–17.6) | 46 |
| Ovary | -- | -- | 6 (5.1–6.9) | 2 | 6 (5.1–6.9) | 2 |
|
| ||||||
| Breast | -- | -- | 4 (3.6–4.4) | 20 | 4 (3.6–4.4) | 20 |
| Colorectum | 1 (0.97–1.03) | 2 | 0.1 (0.08–0.12) | 0 | 0.8 (0.77–0.83) | 2 |
|
| ||||||
| Colorectum | 3 (2.9–3.1) | 4 | 2 (1.8–2.2) | 3 | 2 (1.8–2.2) | 7 |
|
| ||||||
| Colorectum | 0.5 (0.47–0.53) | 1 | 0.4 (0.38–0.42) | 1 | 0.4 (0.38–0.42) | 2 |
| Stomach | 0.7 (0.67–0.73) | 0 | 0.5 (0.48–0.52) | 0 | 0.5 (0.48–0.52) | 0 |
Estimated proportion and number of incident cancer cases attributable to all evaluated risk factors and estimated total number of cancer cases in adults aged 30 years and older in Israel in 2015, by cancer type.
| Cancer | % PAF (95% CI) | Attributable Cases | Total No. of Cases in 2015 |
|---|---|---|---|
| Lung | 84.8 (81.5–88.1) | 2104 | 2482 |
| Pancreas | 22.5 (20.3–24.7) | 195 | 867 |
| Stomach | 36.2 (33.8–38.6) | 256 | 708 |
| Kidney | 42.0 (37.9–46.1) | 358 | 853 |
| Colorectum | 28.3 (27.0–29.6) | 861 | 3047 |
| Bladder | 46.4 (44.3–48.5) | 714 | 1539 |
| Corpus uteri | 29.7 (27.8–31.6) | 228 | 767 |
| Thyroid | 8.6 (7.8–9.4) | 87 | 1008 |
| Breast | 12.0 (11.3–12.7) | 652 | 5459 |
| Ovary | 4.6 (4.0–5.2) | 18 | 392 |
The proportion and number of incident cancer cases (out of all cancer) in adults aged 30 years and older in Israel attributable to each evaluated risk factor, by risk factor.
| Risk Factor | % PAF (95% CI) | Attributable Cases |
|---|---|---|
| Smoking | 20.9 (19.7–22.1) | 3579 |
| Excess body weight | 9.1 (8.2–10.0) | 1566 |
| Alcohol intake | 1.5 (1.1–1.9) | 259 |
| Red meat consumption | 0.3 (0.26–0.34) | 54 |
| Processed meat consumption | 0.09 (0.04–0.14) | 16 |
| All factors combined | 32.0 (28.8–35.2) | 5473 |